510(k) Report

510(k) · Cleared

Cleared

Flexiplan Brachytherapy Treatment Planning System

K081112510(k) AbbreviatedCleared Jul 29, 2008102-day reviewClass II21 CFR 892.5050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Isodose Control B.V. · MUJ System, Planning, Radiation Therapy Treatment

Cleared on Jul 29, 2008 as substantially equivalent to K983343 (Nucletron Corp., 1999) and 1 other predicate after a 102-day review. Its family tree reaches back 2 generations to 1991. 3 later devices descend from it.

Decided
Jul 29, 2008
Review
102 days
Class
Class II
Product code
MUJ
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to K911612 (1991). 3 ancestors in all. 3 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2000: 1 other ancestor2009: 1 descendant cleared2013: 1 descendant cleared2015: 1 descendant clearedK911612 · Nucletron Planning System · Nucletron-Oldelft Corp. · 1991K983343 · Plato Brachytheraphy, Model V. 14.0 · Nucletron Corp. · 19991990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 1 descendant2 generations forward: 1 descendant3 generations forward: 1 descendant K983343 · Plato Brachytheraphy, Model V. 14.0 · Nucletron Corp. · 1999K911612 · Nucletron Planning System · Nucletron-Oldelft Corp. · 19910
  1. Root · 2 generations backK911612 Nucletron Planning SystemNucletron-Oldelft Corp. · 1991
  2. 1 generation backK983343 Plato Brachytheraphy, Model V. 14.0Nucletron Corp. · 1999
  3. This deviceK081112 Flexiplan Brachytherapy Treatment Planning SystemIsodose Control B.V. · 2008
  4. Descendant · cites it directly · 2 of its ownK091145 Flexiplan 3D and 3D+Isodose Control B.V. · 2009
  5. Descendant · 2 generations on · 1 of its ownK123263 Hdrplus, Add in Prostate Module for HdrplusEckert & Ziegler Bebig GmbH · 2013
  6. Descendant · 3 generations on · 0 of its ownK141900 Sagiplan, Sagiplan Prostate Module Add on, Sagiplan Including…Eckert & Ziegler Bebig GmbH · 2015 · Recalled

Most influential descendants

Showing 3 of 3 · See all
  • K091145Flexiplan 3D and 3D+Isodose Control B.V. · 2009 · cites it directly2descendants
  • K123263Hdrplus, Add in Prostate Module for HdrplusEckert & Ziegler Bebig GmbH · 2013 · 2 generations on1descendant
  • K141900Sagiplan, Sagiplan Prostate Module Add on, Sagiplan Including Prostate ModuleEckert & Ziegler Bebig GmbH · 2015 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K911612Nucletron Planning SystemNucletron-Oldelft Corp.1991—
−1K983343Plato Brachytheraphy, Model V. 14.0Nucletron Corp.1999—
0 (this device)K081112Flexiplan Brachytherapy Treatment Planning SystemIsodose Control B.V.2008—
+1K091145Flexiplan 3D and 3D+Isodose Control B.V.2009—
+2K123263Hdrplus, Add in Prostate Module for HdrplusEckert & Ziegler Bebig GmbH2013—
+3K141900Sagiplan, Sagiplan Prostate Module Add on, Sagiplan Including Prostate ModuleEckert & Ziegler Bebig GmbH20151

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200010

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200910
201310
201510
FIG. 1 — Lineage of K081112, 1991–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MUJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MUJ device

  1. #1 K232799 syngo.via RT Image Suitescore 18.6 · 19 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K983343Plato Brachytheraphy, Model V. 14.0
Summary page 1
…Manufacturer 510(k) # PLATO BPS Nucletron B.V. K983343 BrachyVision Varian Medical Systems Inc K992762 5.4. Description of the Device 5.4.1…
Nucletron Corp.1999—
*K992762Brachyvision 6.0
Summary page 1
…S Nucletron B.V. K983343 BrachyVision Varian Medical Systems Inc K992762 5.4. Description of the Device 5.4.1. Flexiplan Flexiplan is a software package which runs on a Windows - based PC and is used b…
Varian Assoc., Inc.20001

Also cleared against K983343: 5 other devices →

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K091145Flexiplan 3D and 3D+Isodose Control B.V.20092

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 17 years and passes through 3 companies; a new generation was cleared every 9.3 years on median.
  • 1 of the 3 ancestors has a recall of any class.
  • Of its descendants, K091145 (Isodose Control B.V., 2009) has gone furthest, with 2 descendants of its own.
  • 5 other devices also cite its predicate K983343.

How does its category compare?

All MUJ devices

MUJ System, Planning, Radiation Therapy Treatment: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · MUJ

10in 2025

2007: 42008: 92009: 162010: 112011: 92012: 82013: 52014: 92015: 132016: 52017: 72018: 72019: 92020: 92021: 112022: 82023: 102024: 92025: 102026 (partial year): 9
2007high 16 (2009) · low 4 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MUJ

186in 2025

2007: 67 days median2008: 63 days median2009: 84 days median2010: 56 days median2011: 103 days median2012: 59 days median2013: 64 days median2014: 108 days median2015: 78 days median2016: 80 days median2017: 30 days median2018: 53 days median2019: 56 days median2020: 104 days median2021: 87 days median2022: 168 days median2023: 140 days median2024: 122 days median2025: 186 days median2026 (partial year): 233 days median
2007high 233 (2026) · low 30 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MUJ

2in 2023

2007: 42008: 102009: 112010: 232011: 172012: 42013: 62014: 22015: 72016: 132017: 42018: 32019: 42020: 22021: 42022: 32023: 22026 (partial year): 2
2007high 23 (2010) · low 0 (2024)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MUJ

21in 2025

2007: 242008: 512009: 242010: 782011: 732012: 392013: 332014: 352015: 302016: 272017: 162018: 252019: 252020: 262021: 152022: 222023: 762024: 92025: 21
2007high 78 (2010) · low 9 (2024)2025

MAUDE reports naming product code MUJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007467424
20089631051
200916841124
201011562378
201191031773
2012859439
2013564633
20149108235
20151378730
20165801327
2017730416
2018753325
2019956425
20209104226
20211187415
20228168322
202310140276
2024912209
202510186021
202692332—

What is it indicated for?

Flexiplan is a Brachytherapy Treatment Planning System used by medical professionals.

Flexiplan is used for the creation of HDR or PDR treatment plans for remote afterloader based brachytherapy. It especially supports the Flexitron Remote Afterloader from Isodose Control.

Flexiplan calculates a proposed treatment course based on imported clinical images and other user entered data. Flexiplan supports the evaluation of clinical images in calculating the local and global dose to organs at risk and target volume.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K081112: Flexiplan Brachytherapy Treatment Planning System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K081112

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026